4//SEC Filing
Nagler David 4
Accession 0001209191-17-061539
CIK 0001628738other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:05 PM ET
Size
5.5 KB
Accession
0001209191-17-061539
Insider Transaction Report
Form 4
Nagler David
SVP, HR & Corp. Affairs
Transactions
- Award
Stock Option (right to buy)
2017-11-16+50,000→ 50,000 totalExercise: $27.39Exp: 2027-11-16→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares monthly, beginning December 16, 2017, with 100% of the total shares vested and exercisable on November 16, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
Audentes Therapeutics, Inc.
CIK 0001628738
Entity typeother
Related Parties
1- filerCIK 0001416175
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 5:05 PM ET
- Size
- 5.5 KB